Al-Harthi L, Roebuck K A, Landay A
Department of Immunology/Microbiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.
J Clin Immunol. 1998 Mar;18(2):124-31. doi: 10.1023/a:1023246800353.
Cytokine dysregulation is evident in HIV-1 infection and it may play an important role in HIV-1 pathogenesis. Administration of T helper cytokines potentially may restore the functional abnormalities to the HIV-1 immune response. Type 1-like cytokines, IL-2, IL-12, and IL-15, are candidates for immune-based therapy for HIV. Given their potential therapeutic use, we determined the effects of IL-2, IL-12, and IL-15 on HIV-1 replication in both primary blood mononuclear cells (PBMC) and the T-cell line, Kit 225-K6. We demonstrate that both IL-2 and IL-12 induce a similar level of HIV-1 replication (9- and 11-fold, respectively) in mitogen-stimulated PBMC. The effect of IL-2 plateaued by day 6, while that of IL-12 continued to increase HIV-1 expression. IL-15 induced a 2.5-fold increase in HIV-1 expression that remained at the same level through day 6. In Kit 225-K6, an IL-2-dependent T cell line, IL-12 and IL-15 enhanced HIV-1 replication by 5- and 3.5-fold over IL-2-treated cultures, respectively. IL-2-, IL-12-, and IL-15-mediated induction of HIV was independent of direct HIV-1 LTR activation, since none of the cytokines induced LTR activity from transfected reporter gene constructs. The cytokine-mediated induction of HIV-1 expression was also independent of cellular proliferation. In PBMC, the IL-12-mediated effect was partially mediated by endogenous cytokine production of IL-1beta and IL-7, whereas in Kit 225-K6, TNFalpha, INFgamma, IL-1beta, and IL-7 did not contribute significantly to the IL-12-mediated effect. IL-15 effect on HIV-1 in PBMC was independent of endogenous cytokine production. However, in Kit 225-K6, neutralizing antibodies to IL-7 had a significant effect on HIV-1 expression. These data suggest that IL-2, IL-12, and IL-15 increase HIV-1 replication predominantly through a posttranscriptional mechanism that may be enhanced by endogenous cytokine production.
细胞因子失调在HIV-1感染中很明显,并且可能在HIV-1发病机制中起重要作用。给予辅助性T细胞细胞因子可能会恢复HIV-1免疫反应的功能异常。1型细胞因子,如白细胞介素-2(IL-2)、白细胞介素-12(IL-12)和白细胞介素-15(IL-15),是用于HIV免疫治疗的候选药物。鉴于它们潜在的治疗用途,我们确定了IL-2、IL-12和IL-15对原代血液单核细胞(PBMC)和T细胞系Kit 225-K6中HIV-1复制的影响。我们证明,在丝裂原刺激的PBMC中,IL-2和IL-12均诱导相似水平的HIV-1复制(分别为9倍和11倍)。IL-2的作用在第6天达到平台期,而IL-12的作用则持续增加HIV-1表达。IL-15诱导HIV-1表达增加2.5倍,并在第6天保持在同一水平。在IL-2依赖的T细胞系Kit 225-K6中,与IL-2处理的培养物相比,IL-12和IL-15分别使HIV-1复制增强了5倍和3.5倍。IL-2、IL-12和IL-15介导的HIV诱导独立于直接的HIV-1长末端重复序列(LTR)激活,因为这些细胞因子均未从转染的报告基因构建体诱导LTR活性。细胞因子介导诱导HIV-1表达也独立于细胞增殖。在PBMC中,IL-12介导的作用部分由内源性细胞因子IL-1β和IL-7的产生介导,而在Kit 225-K6中,肿瘤坏死因子α(TNFα)、干扰素γ(INFγ)、IL-1β和IL-7对IL-12介导的作用没有显著贡献。IL-15对PBMC中HIV-1的作用独立于内源性细胞因子产生。然而,在Kit 225-K6中,针对IL-7的中和抗体对HIV-1表达有显著影响。这些数据表明,IL-2、IL-12和IL-15主要通过转录后机制增加HIV-1复制,内源性细胞因子产生可能会增强这种机制。